Raajit K. Rampal

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 37 papers. Top paper: “A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia”.

A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia

Blood(2022)10.1182/blood.2021012743

N/A

3.6DataRank · unranked

129 citations

Heidi E. Kosiorek, Josef T. Prchal, Alessandro Rambaldi, Dmitriy Berenzon, Abdulraheem Yacoub +38 more

Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase

Blood Advances(2020)10.1182/bloodadvances.2020002119

N/A

2.2DataRank · unranked

73 citations

Raajit K. Rampal, Heidi Kosiorek, Rupali Bhave, Elizabeth O. Hexner, Eunice S. Wang +22 more

Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: a single-centre, single-arm, phase 2 trial

The Lancet Haematology(2020)10.1016/s2352-3026(20)30209-x

N/A

0.843DataRank · unranked

21 citations

Xiaoli Mi, Alexander Penson, Stella Paffenholz, Kelsey Alvarez, Allison Sigler +10 more

Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trial

Nature Medicine(2025)10.1038/s41591-025-03572-3

N/A

0.664DataRank · unranked

40 citations

Sebastian Grosicki, Dominik Chraniuk, Elisabetta Abruzzese, Prithviraj Bose, Aaron T. Gerds +23 more

Neurologic and oncologic features of Erdheim–Chester disease: a 30-patient series

Neuro-Oncology(2020)10.1093/neuonc/noaa008

N/A

0.617DataRank · unranked

60 citations

Vaios Hatzoglou, Gary A. Ulaner, Raajit K. Rampal, David M. Hyman, Omar Abdel-Wahab +10 more

BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformation

Blood(2022)10.1182/blood.2021014465

N/A

0.542DataRank · unranked

36 citations

Wenbin An, Hua Wang, Timour Baslan, Shoron Mowla, Aishwarya Krishnan +13 more

Interferon Therapy in Myelofibrosis: Systematic Review and Meta-analysis

Clinical Lymphoma Myeloma & Leukemia(2020)10.1016/j.clml.2020.05.018

N/A

0.464DataRank · unranked

21 citations

Smith Giri, Rong Wang, Nikolai A. Podoltsev, Christina Williamson, Raajit K. Rampal +4 more

Preclinical efficacy of CDK7 inhibitor–based combinations against myeloproliferative neoplasms transformed to AML

Blood(2024)10.1182/blood.2024026388

N/A

0.395DataRank · unranked

10 citations

Christopher P. Mill, Prithviraj Bose, Lucia Masárová, Naveen Pemmaraju, Andrew Dunbar +18 more

Preclinical efficacy of tasquinimod-based combinations in advanced myeloproliferative neoplasms in blastic phase

Blood Advances(2025)10.1182/bloodadvances.2025016898

N/A

0.262DataRank · unranked

4 citations

Lucia Masárová, Christopher P. Mill, Christine Birdwell, Kaberi Das, Hanxi Hou +16 more

Serum antibody response in patients with philadelphia-chromosome positive or negative myeloproliferative neoplasms following vaccination with SARS-CoV-2 spike protein messenger RNA (mRNA) vaccines

Leukemia(2021)10.1038/s41375-021-01457-1

N/A

0DataRank · unranked

6 citations

Linda Ouyang, Andriy Derkach, Alexandra Sherman, Susan J. McCall, Christopher Famulare +6 more

Baseline risk of hematologic malignancy at initiation of frontline PARP inhibitor maintenance for BRCA1/2-associated ovarian cancer

Gynecologic Oncology Reports(2021)10.1016/j.gore.2021.100873

N/A

0DataRank · unranked

12 citations

Duaa H. Al-Rawi, Ying Liu, Maria M. Rubinstein, Claire F. Friedman, Raajit K. Rampal +4 more

CXCL8/CXCR2 signaling mediates bone marrow fibrosis and represents a therapeutic target in myelofibrosis

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.12.08.471791

N/A

0DataRank · unranked

6 citations

Dongjoo Kim, Min Lü, Mirko Farina, Julie L. Yang, Young Joo Park +29 more

Outcomes of allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A systematic review and meta-analysis.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.7045

N/A

0DataRank · unranked

0 citations

Amar H. Sheth, Shaurey Vetsa, Alyssa Grimshaw, Smith Giri, Nikolai A. Podoltsev +7 more

HMGA1 chromatin regulators induce transcriptional networks involved in GATA2 and proliferation during MPN progression

Blood(2022)10.1182/blood.2021013925

N/A

0DataRank · unranked

46 citations

Jung‐Hyun Kim, Wenyan Lü, Donna M. Williams, Joseph Kim, Leslie Cope +16 more

Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm–blast phase

JCI Insight(2022)10.1172/jci.insight.156534

N/A

0DataRank · unranked

6 citations

Raajit K. Rampal, Cing Siang Hu, Joseph Tripodi, Noushin Farnoud, Bruce Petersen +12 more

Enhanced clinical assessment of hematologic malignancies through routine paired tumor:normal sequencing

medRxiv(2022)10.1101/2022.10.03.22280675

N/A

0DataRank · unranked

1 citations

Mark D. Ewalt, Gowtham Jayakumaran, Iwona Kiecka, Anita S. Bowman, JinJuan Yao +50 more

Enhanced clinical assessment of hematologic malignancies through routine paired tumor:normal sequencing

Research Square(2022)10.21203/rs.3.rs-2094202/v1

N/A

0DataRank · unranked

0 citations

Mark D. Ewalt, Gowtham Jayakumaran, Iwona Kiecka, Anita S. Bowman, JinJuan Yao +50 more

Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia: an appraisal of the new WHO and IC classifications and ELN risk stratification

medRxiv(2022)10.1101/2022.12.26.22283876

N/A

0DataRank · unranked

0 citations

David Nemirovsky, Christopher Famulare, Noushin Farnoud, Abhinita Mohanty, Zoe S. Stone-Molloy +22 more

CXCL8/CXCR2 signaling mediates bone marrow fibrosis and represents a therapeutic target in myelofibrosis

Blood(2023)10.1182/blood.2022015418

N/A

0DataRank · unranked

37 citations

Dongjoo Kim, Min Lü, Mirko Farina, Robert L. Bowman, Julie L. Yang +34 more

A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0276

N/A

0DataRank · unranked

34 citations

Anna Ritá Migliaccio, Heidi Kosiorek, Rupali Bhave, Jeanne Palmer, Andrew Kuykendall +29 more

Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing

Nature Communications(2023)10.1038/s41467-023-42585-9

N/A

0DataRank · unranked

29 citations

Mark D. Ewalt, Gowtham Jayakumaran, Iwona Kiecka, Anita S. Bowman, JinJuan Yao +50 more

Outcomes after interruption of targeted therapy in patients with histiocytic neoplasms

British Journal of Haematology(2023)10.1111/bjh.18964

N/A

0DataRank · unranked

22 citations

Benjamin H. Durham, Mariko Yabe, Kseniya Petrova‐Drus, Jasmine H. Francis, Raajit K. Rampal +6 more

Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia

Blood Advances(2023)10.1182/bloodadvances.2023009675

N/A

0DataRank · unranked

19 citations

David Nemirovsky, Christopher Famulare, Noushin Farnoud, Abhinita Mohanty, Zoe S. Stone-Molloy +22 more

Proposals for revised International Working Group–European LeukemiaNet criteria for anemia response in myelofibrosis

Blood(2024)10.1182/blood.2024025802

N/A

0DataRank · unranked

25 citations

Giovanni Barosi, Francesco Passamonti, Juan Carlos Hernández‐Boluda, Prithviraj Bose, Konstanze Döhner +33 more

Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy

British Journal of Haematology(2024)10.1111/bjh.19462

N/A

0DataRank · unranked

16 citations

Benjamin H. Durham, Anne S. Reiner, Mariko Yabe, Kseniya Petrova‐Drus, Ahmet Doǧan +26 more

Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies

Haematologica(2024)10.3324/haematol.2024.285054

N/A

0DataRank · unranked

9 citations

Kseniya Petrova‐Drus, Ryan Ptashkin, Mark D. Ewalt, JinJuan Yao, Ying Liu +43 more

RAF-independent MEK mutations drive refractory histiocytic neoplasms but respond to ERK inhibition

Cancer Cell(2025)10.1016/j.ccell.2025.09.014

N/A

0DataRank · unranked

3 citations

Jean‐François Emile, T Fujino, Julien Haroche, Maxim I. Maron, Alexander M. Lewis +40 more

Leukemia secondary to myeloproliferative neoplasms

Blood(2020)10.1182/blood.2019000943

N/A

0DataRank · unranked

147 citations

Raajit K. Rampal, Ross L. Levine, Andrew Dunbar

Dual targeting of EZH2 and EZH1 drives exit of leukemia stem cells from quiescence and potentiates chemotherapy in acute myeloid leukemia

Blood Cancer Journal(2025)10.1038/s41408-025-01266-0

N/A

0DataRank · unranked

3 citations

Yuki Nishida, Kyung Hee Chang, Andrea Bedoy, Muharrem Müftüoğlu, Wencai Ma +13 more

Survival following allogeneic transplant in patients with myelofibrosis

Blood Advances(2020)10.1182/bloodadvances.2019001084

N/A

0DataRank · unranked

97 citations

Karen K. Ballen, Kwang Woo Ahn, Zhen‐Huan Hu, Haris Ali, Murat O. Arcasoy +63 more

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

The Lancet Haematology(2020)10.1016/s2352-3026(20)30205-2

N/A

0DataRank · unranked

97 citations

Prajwal Boddu, Mrinal M. Patnaik, Jan Philipp Bewersdorf, Maximilian Stahl, Raajit K. Rampal +47 more

PRMT5 Inhibition Modulates E2F1 Methylation and Gene-Regulatory Networks Leading to Therapeutic Efficacy in JAK2V617F-Mutant MPN

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0026

N/A

0DataRank · unranked

81 citations

Neha Bhagwat, Alessandro Pastore, Aliaksandra Radzisheuskaya, Abdul Karzai, Aishwarya Krishnan +21 more

Interferon alpha therapy in essential thrombocythemia and polycythemia vera—a systematic review and meta-analysis

Leukemia(2020)10.1038/s41375-020-01020-4

N/A

0DataRank · unranked

70 citations

Smith Giri, Rong Wang, Nikolai A. Podoltsev, Robert T. Williams, Martin S. Tallman +4 more

Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor

Journal of Clinical Investigation(2020)10.1172/jci139682

N/A

0DataRank · unranked

56 citations

Mark T.A. Donoghue, Caleb Ho, Kseniya Petrova‐Drus, Hikmat Al‐Ahmadie, Samuel A. Funt +22 more

LKB1/ STK11 Is a Tumor Suppressor in the Progression of Myeloproliferative Neoplasms

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1353

N/A

0DataRank · unranked

46 citations

Praveen Suraneni, Hamza Celik, Andrew Volk, Qiang Wen, Te Ling +20 more

Therapeutic Efficacy of Combined JAK1/2, Pan-PIM, and CDK4/6 Inhibition in Myeloproliferative Neoplasms

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4898

N/A

0DataRank · unranked

22 citations

Maria Pinzon-Ortiz, Amritha Varshini Hanasoge Somasundara, Benjamin H. Durham, Richard P. Koche, Barbara Spitzer +15 more

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis—A Systematic Review and Meta-Analysis

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.05.016

N/A

0DataRank · unranked

20 citations

Amar H. Sheth, Shaurey Vetsa, Alyssa Grimshaw, Smith Giri, Nikolai A. Podoltsev +7 more